Published in Infect Immun on September 01, 1988
Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev (2004) 7.51
Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome. Nucleic Acids Res (1990) 2.21
Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium. J Bacteriol (2001) 1.67
In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae. Antimicrob Agents Chemother (1994) 1.65
The proline-rich P65 protein of Mycoplasma pneumoniae is a component of the Triton X-100-insoluble fraction and exhibits size polymorphism in the strains M129 and FH. J Bacteriol (1995) 1.54
A spontaneous hemadsorption-negative mutant of Mycoplasma pneumoniae exhibits a truncated adhesin-related 30-kilodalton protein and lacks the cytadherence-accessory protein HMW1. J Bacteriol (1995) 1.38
Sequence divergence in the ORF6 gene of Mycoplasma pneumonia. J Bacteriol (1994) 1.36
Spatial arrangement of gene products of the P1 operon in the membrane of Mycoplasma pneumoniae. Infect Immun (1994) 1.22
Localization and biochemical characterization of the ORF6 gene product of the Mycoplasma pneumoniae P1 operon. Infect Immun (1992) 1.22
The immunodominant 90-kilodalton protein is localized on the terminal tip structure of Mycoplasma pneumoniae. Infect Immun (1993) 1.15
Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters. Antimicrob Agents Chemother (1993) 1.14
In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae. Antimicrob Agents Chemother (2001) 1.12
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. Antimicrob Agents Chemother (1994) 1.09
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae. Antimicrob Agents Chemother (1993) 0.95
Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines. Infect Immun (1988) 0.87
Immunoblot analyses of chimpanzee sera after infection and after immunization and challenge with Mycoplasma pneumoniae. Infect Immun (1994) 0.80
Biological activities of monoclonal antibodies to Mycoplasma pneumoniae membrane glycolipids. Infect Immun (1989) 0.78
Animal model of Mycoplasma fermentans respiratory infection. BMC Res Notes (2013) 0.76
Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc Natl Acad Sci U S A (1962) 14.59
A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) (1966) 6.23
EXPERIMENTAL INFECTION WITH MYCOPLASMA PNEUMONIAE (EATON'S AGENT). J Exp Med (1965) 5.36
Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains. J Bacteriol (1969) 3.96
Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis (1971) 3.73
Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture. Proc Soc Exp Biol Med (1969) 3.53
Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease. Infect Immun (1970) 1.90
Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae. J Immunol (1972) 1.67
Ecology of Mycoplasma pneumoniae infections in marine recruits at Parris Island, South Carolina. Am J Epidemiol (1969) 1.58
Immunopathology of experimental Mycoplasma pneumoniae disease. Infect Immun (1971) 1.58
Distinction of species and strains of mycoplasmas (mollicutes) by genomic DNA fingerprints with an rRNA gene probe. J Clin Microbiol (1988) 1.48
The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period. Infect Immun (1987) 1.48
Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. J Infect Dis (1977) 1.45
Ciliostatic, hemagglutinating, and proteolytic activities in a cell extract of Mycoplasma pneumoniae. Infect Immun (1980) 1.43
Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J Biol Med (1984) 1.34
Serologic evidence of chlamydial and mycoplasmal pharyngitis in adults. Science (1983) 1.32
Mycoplasmacidal action of normal tissue extracts. Nature (1969) 1.09
Acquired immunity to Mycoplasma pneumoniae. Pneumonia in hamsters. Microbiol Immunol (1978) 1.08
Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines. Isr J Med Sci (1981) 1.03
Aerosol evaluations of the DeVilbiss No. 40 and Vaponefrin nebulizers. Appl Environ Microbiol (1976) 1.00
Protective efficacy of Mycoplasma pneumoniae polysaccharides. Isr J Med Sci (1981) 0.90
Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines. Infect Immun (1988) 0.87
Effect of monoclonal antibodies to the attachment-tip on experimental Mycoplasma pneumoniae infection of hamsters. A preliminary report. Isr J Med Sci (1984) 0.85
Further studies on the Mycoplasma pneumoniae extract: ciliostatic and cell recruitment activities. Isr J Med Sci (1987) 0.84
Mycoplasma pneumoniae attachment to WiDr cell cultures: competitive inhibition assays. Yale J Biol Med (1984) 0.79
Mycoplasma pneumonia: failure of erythromycin therapy. Scott Med J (1980) 0.78
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature (1999) 12.32
Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell (1999) 9.05
DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science (2000) 7.85
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature (1998) 7.38
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet (1986) 5.95
The mycoplasmas. Microbiol Rev (1978) 5.43
Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell (2001) 5.39
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature (2001) 5.07
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrob Agents Chemother (1989) 4.79
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res (1998) 4.39
Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci U S A (1993) 4.35
Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature (1998) 4.18
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 3.96
New ages for the last Australian megafauna: continent-wide extinction about 46,000 years ago. Science (2001) 3.91
gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother (1989) 3.67
Molecular biology and genetics of mycoplasmas (Mollicutes). Microbiol Rev (1985) 3.58
Signalling from endoplasmic reticulum to nucleus: transcription factor with a basic-leucine zipper motif is required for the unfolded protein-response pathway. Genes Cells (1996) 3.58
Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med (2000) 3.44
A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut (2004) 3.35
Reconstruction of biological membranes. Biochim Biophys Acta (1972) 3.33
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A (1987) 3.32
Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol (1984) 3.20
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell (2001) 2.97
Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (1999) 2.96
Electrophoretic patterns of membrane proteins of Mycoplasma. J Bacteriol (1967) 2.86
Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut (1998) 2.84
Mycoplasmas (Mollicutes) have a low number of rRNA genes. J Bacteriol (1984) 2.62
Reassembly of Mycoplasma membranes disaggregated by detergents. Arch Biochem Biophys (1968) 2.60
Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology (1996) 2.59
Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol (1999) 2.55
In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity (1998) 2.54
Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol (2003) 2.52
Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis (1999) 2.52
Membrane subunits of Mycoplasma laidlawii and their assembly to membranelike structures. Proc Natl Acad Sci U S A (1965) 2.50
Ribosomal RNA genes in Mycoplasma. Nucleic Acids Res (1982) 2.46
Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med (2000) 2.37
Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev (1993) 2.36
Identification of Mycoplasma and other microorganisms by polyacrylamide-gel electrophoresis of cell proteins. J Bacteriol (1967) 2.36
Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat Genet (1997) 2.28
Physiology of mycoplasmas. Adv Microb Physiol (1973) 2.27
Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut (1999) 2.25
Mycoplasma taxonomy studiedy electrophoresis of cell proteins. J Bacteriol (1968) 2.23
Influence of lipid components of Mycoplasma laidlawii membranes on osmotic fragility of cells. J Bacteriol (1966) 2.22
Localization of Enzymes in Mycoplasma. J Bacteriol (1965) 2.21
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest (1996) 2.21
Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development (2001) 2.19
Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med (1999) 2.13
Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem (1995) 2.09
The relationship between facet joint osteoarthritis and disc degeneration of the lumbar spine: an MRI study. Eur Spine J (1999) 2.07
Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age Ageing (2000) 1.99
Adherence of Mycoplasma gallisepticum to human erythrocytes. Infect Immun (1978) 1.98
Structure and function in mycoplasma. Annu Rev Microbiol (1969) 1.98
Complete nucleotide sequence of the 26S rRNA gene of Physarum polycephalum: its significance in gene evolution. Proc Natl Acad Sci U S A (1983) 1.98
Afadin: A key molecule essential for structural organization of cell-cell junctions of polarized epithelia during embryogenesis. J Cell Biol (1999) 1.96
Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene (1999) 1.91
Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthritis Cartilage (2009) 1.90
Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice. J Immunol (1981) 1.88
Fractionation of mycoplasma cells for enzyme localization. Life Sci (1965) 1.81
The relationship between disc degeneration, facet joint osteoarthritis, and stability of the degenerative lumbar spine. J Spinal Disord (2000) 1.81
Snowboard head injury: prospective study in Chino, Nagano, for two seasons from 1995 to 1997. J Trauma (1999) 1.79
Growth phases of Mycoplasma in liquid media observed with phase-contrast microscope. J Bacteriol (1966) 1.74
Inducer exclusion in Escherichia coli by non-PTS substrates: the role of the PEP to pyruvate ratio in determining the phosphorylation state of enzyme IIAGlc. Mol Microbiol (1998) 1.73
Immunogenicity of Mycoplasma pneumoniae glycolipids: a novel approach to the production of antisera to membrane lipids. Proc Natl Acad Sci U S A (1970) 1.73
The outer membrane of Proteus mirabilis. I. Isolation and characterization of the outer and cytoplasmic membrane fractions. Biochim Biophys Acta (1975) 1.72
Genomic and phenotypic analyses of Mycoplasma pneumoniae strains. Infect Immun (1982) 1.72
Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest (1995) 1.72
Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J Exp Med (1998) 1.70
DNA probes for detection and identification of Mycoplasma pneumoniae and Mycoplasma genitalium. J Clin Microbiol (1987) 1.70
Physiological and serological comparisons among strains of Mycoplasma granularum and Mycoplasma laidlawii. J Bacteriol (1968) 1.69
Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J Immunol (1990) 1.69
Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem (2001) 1.68
Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus. J Mol Cell Cardiol (2001) 1.67
Fully automatic quantification of knee osteoarthritis severity on plain radiographs. Osteoarthritis Cartilage (2008) 1.67
Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury. J Neurosurg (1993) 1.67
Immunological analysis of Mycoplasma membranes. J Bacteriol (1969) 1.66
The cell membrane of mycoplasma. Ann N Y Acad Sci (1967) 1.65
Splenic artery embolization before laparoscopic splenectomy in children. Surg Endosc (2005) 1.65
Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells (2001) 1.65
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med (2000) 1.64
Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron (1997) 1.63
Procaryotic and eucaryotic traits of DNA methylation in spiroplasmas (mycoplasmas). J Bacteriol (1985) 1.62
Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodies. Vox Sang (1991) 1.60
Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab (1978) 1.60
Cholesterol requirement of mycoplasmas. J Bacteriol (1970) 1.60
Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias. J Cardiovasc Electrophysiol (2001) 1.59
Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta (1990) 1.57
Localization of enzymes in Ureaplasma urealyticum (T-strain mycoplasma). J Bacteriol (1977) 1.55
Adenosine triphosphatase activity of mycoplasma membranes. J Bacteriol (1966) 1.55
Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54
Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg (1989) 1.54
Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem J (1997) 1.54
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54
Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J Exp Med (2001) 1.53
Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study. Gastrointest Endosc (1999) 1.53